Luca Cantarini Selected Research

autosomal dominant familial Periodic fever

1/2021	Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network.
1/2020	Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network.
6/2018	A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.
7/2017	Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.
11/2015	Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
8/2015	Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.
5/2015	Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
4/2015	Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
9/2014	Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
5/2013	Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Cantarini Research Topics

Disease

30	Uveitis 12/2021 - 08/2010
19	Inflammation (Inflammations) 10/2022 - 04/2010
16	Fever (Fevers) 10/2022 - 07/2012
16	Rheumatoid Arthritis 01/2021 - 01/2014
16	Necrosis 07/2020 - 05/2010
15	autosomal dominant familial Periodic fever 01/2021 - 08/2011
14	Cryopyrin-Associated Periodic Syndromes 01/2020 - 08/2011
13	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 08/2011
11	Pericarditis 01/2022 - 07/2012
11	Adult-Onset Still's Disease 01/2021 - 05/2016
11	Psoriatic Arthritis 01/2020 - 01/2014
11	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2019 - 09/2009
9	Infections 03/2022 - 05/2010
9	Vasculitis (Vasculitides) 01/2022 - 04/2010
9	Mevalonate Kinase Deficiency 01/2020 - 08/2011
8	Behcet Syndrome (Behcet's Syndrome) 11/2020 - 07/2015
6	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2011
6	Knee Osteoarthritis 01/2021 - 04/2007
6	Ankylosing Spondylitis 09/2019 - 01/2014
6	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 04/2012
6	Arthritis (Polyarthritis) 01/2016 - 02/2010
5	Abdominal Pain (Pain, Abdominal) 10/2022 - 05/2010
5	Osteoporosis 10/2022 - 12/2013
5	Pain (Aches) 09/2022 - 02/2010
5	Myositis (Idiopathic Inflammatory Myopathies) 03/2022 - 01/2013
5	Scleritis (Episcleritis) 01/2022 - 10/2017
5	Macular Edema 03/2021 - 06/2015
5	Amyloidosis 01/2020 - 02/2012
5	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 01/2015
4	Exanthema (Rash) 10/2022 - 11/2012
4	Arthralgia (Joint Pain) 10/2022 - 05/2010
4	Dermatomyositis (Dermatopolymyositis) 10/2022 - 01/2013
4	Hepatitis B 03/2022 - 03/2015
4	Serositis 01/2022 - 11/2012
4	Anterior Uveitis 12/2021 - 11/2016
4	Retinal Vasculitis 03/2021 - 01/2017
4	Pharyngitis (Sore Throat) 01/2020 - 07/2012
4	Panuveitis 01/2020 - 06/2015
4	Axial Spondyloarthritis 01/2020 - 07/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2015
3	COVID-19 10/2022 - 01/2021
3	Polymyositis 10/2022 - 01/2017
3	Overweight 05/2022 - 01/2021
3	Proteinuria 01/2021 - 07/2015
3	Aphthous Stomatitis (Aphthous Ulcer) 01/2020 - 07/2012
3	Lymphadenitis (Adenitis) 01/2020 - 07/2012
3	Sacroiliitis 11/2019 - 07/2014
3	Blau syndrome 10/2017 - 01/2013
3	Neoplasms (Cancer) 02/2017 - 05/2010
3	Tuberculosis (Tuberculoses) 02/2017 - 01/2015
3	Gout 05/2016 - 01/2015
3	Osteoarthritis 12/2015 - 04/2007
2	Macrophage Activation Syndrome 10/2022 - 10/2013

Drug/Important Bio-Agent (IBA)

26	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 07/2012
26	Biological ProductsIBA 12/2021 - 04/2012
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2020 - 05/2010
21	Interleukin-1 (Interleukin 1)IBA 01/2021 - 11/2012
19	Adalimumab (Humira)FDA Link 01/2022 - 05/2015
17	CytokinesIBA 01/2021 - 04/2012
16	Pharmaceutical PreparationsIBA 03/2021 - 02/2010
14	InterleukinsIBA 01/2022 - 05/2013
14	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2013
13	canakinumab FDA Link 01/2020 - 06/2012
12	Colchicine FDA LinkGeneric 01/2022 - 08/2010
12	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 01/2013
11	C-Reactive ProteinIBA 05/2022 - 06/2017
10	SteroidsIBA 01/2022 - 09/2015
10	InflammasomesIBA 01/2021 - 01/2013
9	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2016
9	Infliximab (Remicade)FDA Link 02/2019 - 02/2015
8	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2013
8	tocilizumab (atlizumab)FDA Link 01/2020 - 09/2014
7	GlucocorticoidsIBA 01/2022 - 10/2013
7	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 09/2012
7	Etanercept (Enbrel)FDA Link 01/2020 - 09/2014
7	AutoantibodiesIBA 02/2017 - 08/2011
6	Rituximab (Mabthera)FDA Link 12/2022 - 07/2015
6	Biosimilar PharmaceuticalsIBA 12/2021 - 10/2016
6	AntibodiesIBA 07/2020 - 04/2010
6	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 05/2013
5	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 08/2010
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2022 - 12/2015
4	Monoclonal AntibodiesIBA 03/2019 - 06/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2010
4	Fluorescein (Funduscein)FDA LinkGeneric 07/2017 - 01/2017
4	AdipokinesIBA 03/2013 - 07/2011
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022 - 05/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2017
3	AdiponectinIBA 09/2020 - 07/2011
3	Clodronic Acid (Clodronate)IBA 03/2020 - 03/2013
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020 - 09/2014
3	Diphosphonates (Bisphosphonates)IBA 08/2018 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2013
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 01/2015
3	AA amyloidosisIBA 07/2017 - 07/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 07/2017 - 06/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 03/2016 - 12/2012
3	Alendronate (Alendronate Sodium)FDA LinkGeneric 04/2015 - 06/2008

Therapy/Procedure

37	Therapeutics 03/2022 - 04/2007
9	Biological Therapy 12/2021 - 03/2015